RetinalGenix Technologies Net Debt per Share
Net Debt per Share of RetinalGenix Technologies (RTGN) as of Nov 8, 2026.
Get this data via API
Financial Data API
Net Debt per Share
0.00USD
Last updated:
Net Debt per Share of RetinalGenix Technologies is 2022 0.00 USD. Net Debt per Share of RetinalGenix Technologies was 2021 - USD. It decreases by % lower compared to the previous year.
The RetinalGenix Technologies Net Debt per Share history
| YEAR | Net Debt per Share | YoY |
|---|---|---|
| 0.00USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
RetinalGenix Technologies Stock analysis
What does RetinalGenix Technologies do? RetinalGenix Technologies Inc, based in Petaluma, California, is a medical device company focused on ocular health. The company develops innovative solutions for screening, monitoring, diagnosing, and treating sight-threatening disorders, particularly diabetic retinopathy and maculopathy. Its key products include the Retinal Imaging Screening Device, a portable system offering a 200-degree field of view without pupil dilation, and RetinalCam, a home monitoring device with 24/7 physician access for real-time communication. Both devices aim to address vision loss and blindness through advanced imaging technology. RetinalGenix Technologies is one of the most popular companies on Eulerpool.
Frequently Asked Questions about RetinalGenix Technologies stock
On Eulerpool you can find the complete historical development of Net Debt per Share RetinalGenix Technologies since 2006 – with annual values, charts, and detailed analysis.
Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Other — RetinalGenix Technologies
All Key Metrics — RetinalGenix Technologies
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth